KPV

In plain English

KPV is a tiny peptide, just three amino acids, cut from the end of alpha-MSH, a natural hormone that calms inflammation. It keeps the calming effect without the tanning effect, which makes it popular for gut problems, skin irritation and general inflammation.

What it's used for

  • Gut inflammation, including inflammatory bowel conditions
  • Skin inflammation and wound healing
  • General inflammation and immune balance

Benefits

In animal and lab studies, KPV has shown:

  • Reduced inflammation and tissue damage in models of colitis
  • Lower levels of inflammatory signals in gut and skin cells
  • Faster wound healing and antimicrobial activity

Users report calmer digestion and less bloating, and improvements in irritated skin.

How it works

In simple terms: KPV switches down one of the cell’s main inflammation alarms.

It enters cells and blocks the NF-κB pathway, which controls many inflammatory signals. In the gut, it is carried into cells lining the intestine, where inflammation in conditions like colitis is concentrated. Unlike full alpha-MSH, it does not darken the skin.

Development history

  • 1980s–1990s: Researchers studying alpha-MSH find its anti-inflammatory power lies largely in its last three amino acids.
  • 2000s: Animal studies show strong effects in colitis and skin inflammation.
  • Today: A popular gut and skin peptide, often combined with BPC-157.

Typical protocols

Educational information only, not medical advice. The information below describes how this peptide has been used in research, on prescription labels or by users. It is not a recommendation. Talk to a qualified healthcare professional before starting, stopping or changing anything.

These ranges are what users commonly report.

Use Dose Frequency Length
Gut or general inflammation 200–500 mcg Once or twice daily 4–8 weeks

Cycling

Commonly run for 4–8 weeks, followed by a break.

Administration options

Subcutaneous injection, usually in the belly.

Reconstitution and dosing calculator

KPV usually comes in 5 mg or 10 mg vials and is commonly mixed with 2 mL of bacteriostatic water.

1Peptide in the vial

The total amount printed on the vial label.

2Bacteriostatic water added

More water makes each dose a bigger, easier-to-measure draw. It does not change how much peptide is in the vial.

3Dose per injection

Use the dose from your protocol or your clinician. 1 mg = 1,000 mcg.

4Your syringe

All three are U-100 insulin syringes: 100 units = 1 mL. Smaller barrels make small doses easier to read.

Draw your syringe to

– units

Volume to draw
–
Concentration
–
Each unit holds
–
Doses per vial
–
Show the math

    This tool does arithmetic only. It does not choose a dose or confirm that any substance is right for you. Double-check every result against your syringe and your clinician’s instructions.

    Side effects and safety

    • Users report that KPV is generally well tolerated. Occasional effects include injection-site redness and mild headache.
    • Long-term effects in people have not been well studied.
    • Avoid during pregnancy and breastfeeding.

    Common stacks

    • BPC-157: the most common pairing for gut repair plus inflammation control.
    • GHK-Cu, BPC-157 and TB-500: combined in the "KLOW" blend.

    Storage

    Powder: refrigerate, dry and away from light.
    After mixing: refrigerate at 2–8 °C and use within about 4 weeks.

    Compare with

    • BPC-157: focuses on tissue repair; KPV focuses on calming inflammation.
    • Alpha-MSH and Melanotan: larger related peptides that also cause tanning.

    Frequently asked questions

    Will KPV tan my skin?

    No. Its tanning activity is removed; only the anti-inflammatory part remains.

    Why pair it with BPC-157?

    BPC-157 supports repair of the gut lining, while KPV calms the inflammation; users find they work well together.

    How long until people notice results?

    Users commonly report changes in digestion within 1–3 weeks.

    References

    1. Dalmasso G, et al. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology. 2008;134(1):166-178.
    2. Kannengiesser K, et al. Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease. Inflamm Bowel Dis. 2008;14(3):324-331.
    Educational information only. Not medical advice. Always consult a qualified healthcare professional.

    More posts